Despite the overall success of the generic drug market, sudden price hikes are becoming more common according to new Schaeffer Center study
Dana Goldman and Anupam Jena write in The Washington Post that the Trump administration may succeed in lowering drug prices by fostering competition and innovation, and possibly ending kickbacks in the supply chain.
Dana Goldman and his colleagues have shown that such subscription models can improve outcomes and save money at the same time.
Pharmacy-benefit managers find ways to boost their bottom line at the expense of employers and patients, writes Geoffrey Joyce in Market Watch.
Even with Medicare’s catastrophic insurance, middle-income seniors can be on the hook for thousands of dollars for their medications each year, write Erin Trish and Geoffrey Joyce in STAT.
Use an interactive graph to see how frequently a co-payment exceeds the price of commonly prescribed drugs and the average size of the overpayment.